SCHEMBL29614545

SCHEMBL29614545

O=CCCc1ccc2c(c1)c1cccnc1n2C1CCC(=O)NC1=O

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 20/20 0.65
CRBN Q96SW2 20/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21997198 1.00 DDB1 (0.65) DDB1CRBN
SCHEMBL22777238 0.94 DDB1 (0.62) DDB1CRBN
SCHEMBL23319594 0.91 DDB1 (0.68) DDB1CRBN
SCHEMBL29614593 0.87 DDB1 (0.72) DDB1CRBN
SCHEMBL24420882 0.87 DDB1 (0.72) DDB1CRBN
SCHEMBL21107900 0.86 DDB1 (0.69) DDB1CRBN
SCHEMBL23319511 0.86 DDB1 (0.69) DDB1CRBN
SCHEMBL22776370 0.86 DDB1 (0.69) DDB1CRBN
SCHEMBL24764819 0.86 DDB1 (0.71) DDB1CRBN
SCHEMBL30043350 0.86 DDB1 (0.71) DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4240743-A1 BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE Prelude Therapeutics, Incorporated (US) 2023-09-13 EP disclosed
WO-2022099117-A1 BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE PRELUDE THERAPEUTICS INCORPORATED (US) 2022-05-12 WO disclosed